Dr. Rosaire Vaillancourt, MD
Claim this profileInstitut Universitaire de Cardiologie et de Pneumologie de Québec
Studies Lung Cancer
Studies Circulating Tumor Cells
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Rosaire Vaillancourt, MD
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Rosaire Vaillancourt, MD has experience with
- Arteries Interruption Before Vein Interruption
- Vein Interruption Before Any Other Surgical Manipulation
Breakdown of trials Rosaire Vaillancourt, MD has run
Lung Cancer
Circulating Tumor Cells
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rosaire Vaillancourt, MD specialize in?
Rosaire Vaillancourt, MD focuses on Lung Cancer and Circulating Tumor Cells. In particular, much of their work with Lung Cancer has involved treating patients, or patients who are undergoing treatment.
Is Rosaire Vaillancourt, MD currently recruiting for clinical trials?
No, Rosaire Vaillancourt, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Rosaire Vaillancourt, MD has studied deeply?
Yes, Rosaire Vaillancourt, MD has studied treatments such as Arteries interruption before vein interruption, Vein interruption before any other surgical manipulation.
What is the best way to schedule an appointment with Rosaire Vaillancourt, MD?
Apply for one of the trials that Rosaire Vaillancourt, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.